COMPASS Pathways plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMPS research report →
About the company
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.
- CEO
- Kabir Kumar Nath
- IPO
- 2020
- Employees
- 166
- HQ
- London, GB
Price Chart
- Market Cap
- $1.16B
- P/E
- -7.45
- P/S
- 0.00
- P/B
- 4.08
- EV/EBITDA
- -3.97
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -151.02%
- ROIC
- -44.02%
- Revenue
- $0 · 0.00%
- Net Income
- $-287,862,000 · -85.57%
- EPS
- $-3.08 · -33.91%
- Op Income
- $-179,037,000
- FCF YoY
- -31.93%
- 52W High
- $14.76
- 52W Low
- $2.25
- 50D MA
- $8.72
- 200D MA
- $6.79
- Beta
- 2.51
- Avg Volume
- 4.04M
Get TickerSpark's AI analysis on CMPS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 27, 26 | Karydas Daphne | other | 21,110 |
| May 27, 26 | SANTINI GINO | other | 30,158 |
| May 27, 26 | Gover Justin D. | other | 21,110 |
| May 27, 26 | JONAS JEFFREY M | other | 21,110 |
| May 27, 26 | Riley Wayne Joseph | other | 21,110 |
| May 27, 26 | McQuade Robert | other | 21,110 |
| May 27, 26 | Norton David Y | other | 21,110 |
| May 27, 26 | Tregoning Kathleen | other | 41,119 |
| May 27, 26 | Tregoning Kathleen | other | 0 |
| Mar 26, 26 | Nath Kabir | other | 367,815 |
Our CMPS coverage
Recent articles, reports, and earnings notes.
Want a deeper read on CMPS?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.